VARIGEN
Varigen Biosciences is developing new technologies for capturing and expressing natural product pathways. Learn about our DNAtrapโข custom cloning service which delivers verified clones of your DNA target (up to 100 kb) in just 10 days at http://varigenbiosciences.com/dnatrap-custom-cloning-service/. Learn about how our BigDNAโข metagenomics libraries can revolutionize natural product discovery at http://varigenbiosciences.com/products/.
VARIGEN
Industry:
Bioinformatics Biotechnology Environmental Engineering Genetics Life Science
Founded:
2016-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.varigenbiosciences.com
Total Employee:
1+
Status:
Active
Contact:
608.444.9518
Total Funding:
555 K USD
Technology used in webpage:
Euro U.S. Server Location
Similar Organizations
Abogen Biosciences
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.
Current Employees Featured
Founder
Investors List
Newchip Accelerator
Newchip Accelerator investment in Non Equity Assistance - Varigen
National Science Foundation
National Science Foundation investment in Grant - Varigen
Official Site Inspections
http://www.varigenbiosciences.com
- Host name: ip-143-95-242-29.iplocal
- IP address: 143.95.242.29
- Location: Los Angeles United States
- Latitude: 34.0549
- Longitude: -118.2578
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90014
More informations about "Varigen"
Varigen - Crunchbase Company Profile & Funding
Organization. Varigen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Varigen Biosciences is developing new technologies for capturing and expressing natural product โฆSee details»
Varigen Biosciences - VentureRadar
Varigen Biosciences Corporation is an NIH- and NSF-funded effort to harness naturally occurring microbial diversity to develop the next generation of natural products through genomics and โฆSee details»
VARIGEN BIOSCIENCES CORPORATION - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for VARIGEN BIOSCIENCES CORPORATION of Middleton, WI. Get the latest business insights from Dun & โฆSee details»
Varigen Biosciences Company Profile | Management and
Varigen Biosciences Profile and History. Varigen is an early-stage life sciences and genomics firm specializing in the development of the next generation of molecular tools for understanding โฆSee details»
Varigen Biosciences - Overview, News & Similar companies
Who is Varigen Biosciences. Varigen is an early-stage life sciences and genomics firm specializing in the development of the next generation of molecular tools for understandi ng โฆSee details»
Synthetic Biology Platform - Terra Bioforge
Terra Bioforge, formerly Varigen Biosciences, is leveraging a portfolio of breakthrough proprietary tools and technology assets to scale production of microbial natural products faster and more efficiently. How we do it How we โฆSee details»
Varigen Biosciences - Products, Competitors, Financials, Employees ...
Varigen Biosciences, YLive, Pluton Biosciences, Microbiotica, and Hexagon Bio develop 5 top solutions to watch out for. Our Innovation Analysts recently looked into emerging technologies โฆSee details»
Varigen Biosciences Corp - VentureRadar
Varigen Biosciences is a pre-clinical drug discovery company focused on biosynthesizing;new natural product drug leads directly from microbial DNA. Previously inaccessible natural product โฆSee details»
Varigen Biosciences Corp.: Drug pipelines, Patents, Clinical trials ...
Explore Varigen Biosciences Corp. with its drug pipeline, therapeutic area, technology platform, .See details»
Varigen Biosciences Corp Details - govtribe.com
Sep 30, 2023 Varigen Biosciences Corp is a biotechnology company that specializes in developing innovative products and services for the life sciences industry. The company โฆSee details»
BioForward Member Profile: Varigen Biosciences
May 20, 2021 Varigen Biosciences is a synthetic biology company focused on manufacturing and creating high-value therapeutic drugs for humans and animals and biocontrol agents for plants. ... What are the key areas of or achievements โฆSee details»
Varigen Biosciences - Home
Varigen Biosciences is developing revolutionary products for the sequence specific capture, amplification, sequencing, and over expression of long DNA (20-150 Kb) to dramatically โฆSee details»
Varigen Biosciences - Company Profile - Tracxn
Varigen Biosciences - Provider of mining services for the natural microbiome for improved enzymes, drugs, and industrial products. Founded by David Mead and Mark Liles in the year โฆSee details»
About - Varigen Biosciences
Varigen Biosciences uses and improves upon this wealth of biodiversity using proprietary methods to create novel VARIants that have beneficial applications for medical, agricultural โฆSee details»
Varigen Biosciences Corp Overview - Salary.com
Varigen Biosciences Corp Information BETA. Headquarters Address: 3220 Deming Way Ste 160, Middleton, Wisconsin. Phone Number: +1 6084449518. Revenue: $0 Million - $1 Million ... The โฆSee details»
Varigen Biosciences CEO and Key Executive Team | Craft.co
Varigen Biosciences's CEO and Co-Founder is David Mead. Other executives include Don Johnson, Vice President, Enzymology; Mark Liles, President and Co-Founder and 1 others. โฆSee details»
Varigen Biosciences Corp (About)
Varigen Biosciences Corp (Madison WI 53562, US). Next generation of natural products and molecular toolsSee details»
Varigen Biosciences Profile - highergov.com
Varigen Biosciences (UEI XLMBJ8BVWPZ3, CAGE 7LWE7) based in Middleton WI federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Varigen Biosciences Corp. - WEDC
Varigen Biosciences Corp. 3220 Deming Way Ste 160 Middleton, WI 53562 https://varizymes.com. Varigen Biosciences has developed revolutionary products for the โฆSee details»
Varigen Biosciences: Revenue, Competitors, Alternatives
Varigen Biosciences. News 2022-04-06 - The metagenomic sequencing market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% โฆSee details»